Picture of Cronos logo

CRON — Cronos News Story

0.000.00%
ca flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Canada's Cronos Group Q2 revenue beats estimates on higher cannabis flower sales

Canada's Cronos Group Q2 revenue beats estimates on higher cannabis flower sales 


Overview

  • Canada cannabis producer's Q2 revenue rose 58% yr/yr, beating analyst expectations

  • Net income turned positive, helped by higher gross profit and foreign currency gains

  • Company repurchased 12.3 mln shares in the first half of 2026


Outlook

  • Company expects CanAdelaar acquisition to close in H2 2026, pending regulatory clearance

  • Company says strong balance sheet supports investment in growth and capital returns


Result Drivers

  • ISRAEL & GERMANY SALES - Higher cannabis flower sales in Israel and Germany, which carry no excise taxes, drove revenue growth

  • SALES MIX & VOLUME - Higher average sales prices, largely driven by a mix shift to Israel and other countries, and higher sales volumes boosted gross profit

  • CURRENCY IMPACT - Strengthening of the New Israeli Shekel versus the U.S. dollar benefited net revenue


Company press release: ID:nGNX1ps22m


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q2 Revenue

Beat

$53.007 mln

$44.20 mln (3 Analysts)

Q2 Net Income

$35.70 mln

Q2 Adjusted EBITDA

Beat

$13.10 mln

$4.05 mln (2 Analysts)

Q2 Gross Profit

$28.50 mln


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the pharmaceuticals peer group is "buy"

  • Wall Street's median 12-month price target for Cronos Group Inc. is C$5.00, about 31.6% above its August 5 closing price of C$3.80

  • The stock recently traded at 27 times the next 12-month earnings vs. a P/E of 47 three months ago


Reuters Recommended Reads

  • Aug 4 - Green Thumb Q2 revenue beats estimates on Minnesota adult-use launch

  • Aug 5 - Verano Q2 revenue tops estimates on retail expansion

  • Aug 4 - Cannabis firm Grown Rogue Q2 revenue rises 41%, lifts outlook


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Cronos

See all news